[Form 4] Zimmer Biomet Holdings, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Paul A. Stellato, Vice President, Controller and Chief Accounting Officer of Zimmer Biomet Holdings, Inc. (ZBH), reported insider transactions dated 09/01/2025. The filing shows 1,281 shares of common stock were acquired upon vesting of restricted stock units (RSUs) at a $0 per-share acquisition price, increasing his beneficial ownership to 4,112 shares; the filing notes 59 of those shares derive from the Employee Stock Purchase Plan. Separately, 402 shares were disposed of in a sale at $105.60 per share, leaving beneficial ownership of 3,710 shares. The Form 4 is signed by an attorney-in-fact on behalf of Mr. Stellato.

Positive

• RSU vesting converted to 1,281 shares, demonstrating compensation alignment with shareholders
• 59 shares from the Employee Stock Purchase Plan were included, indicating participation in the company plan
• Filing appears complete and signed by attorney-in-fact, meeting disclosure requirements

Negative

• Sale of 402 shares at $105.60 reduced direct beneficial ownership to 3,710 shares
• Form does not indicate a Rule 10b5-1 plan or provide rationale for the sale

Insights

Corporate Governance Expert

TL;DR: Insider reported standard RSU vesting and a partial sale; transactions appear routine and disclosed properly.

The reporting shows vesting of 1,281 RSUs converted into shares and a contemporaneous sale of 402 shares at $105.60. The filing documents inclusion of 59 shares from the ESPP and indicates tax withholding via share retention. All material fields are provided: transaction dates, codes, amounts, prices, and resulting beneficial ownership levels. From a governance perspective, the disclosure meets Section 16 requirements and is signed by an attorney-in-fact.

Securities Analyst

TL;DR: Transactions reflect compensation vesting and an executed sale; net change in direct holdings is modest relative to company size.

The record shows the conversion of RSUs into common shares at no cash exercise price and simultaneous withholding of shares for taxes, consistent with typical equity compensation mechanics. The sale of 402 shares at $105.60 reduced direct holdings to 3,710 shares. The filing does not provide intent or planned future trades, and contains no indications of Rule 10b5-1 reliance. Impact on ownership percentages or control is not stated in the filing.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Stellato Paul A

(Last) (First) (Middle)

345 E. MAIN STREET

(Street)

WARSAW IN 46580

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
ZIMMER BIOMET HOLDINGS, INC. [ ZBH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	VP, Controller, CAO

3. Date of Earliest Transaction (Month/Day/Year)
09/01/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/01/2025		M		1,281	A	$0	4,112(1)	D
Common Stock	09/01/2025		F		402(2)	D	$105.6	3,710	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(3)	09/01/2025		M			1,281	09/01/2025	09/01/2025	Common Stock	1,281	$0	0	D

Explanation of Responses:

1. Includes 59 shares acquired under the Employee Stock Purchase Plan on June 30, 2025.

2. Represents shares withheld by the Company to satisfy tax withholding obligations on the vesting of restricted stock units ("RSUs").

3. Each RSU represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock.

	/s/ Matthew R. St. Louis, Attorney-in-Fact for Paul A. Stellato (power of attorney previously filed)	09/02/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions did Paul A. Stellato report on Form 4 for ZBH?

On 09/01/2025 Mr. Stellato reported acquisition of 1,281 shares from RSU vesting and a sale of 402 shares at $105.60 per share.

How many shares does Paul A. Stellato beneficially own after the reported transactions?

Following the transactions reported on the Form 4, Mr. Stellato beneficially owns 3,710 shares.

Did the Form 4 disclose any shares withheld for taxes or ESPP activity?

Yes. The filing states 59 shares were acquired under the Employee Stock Purchase Plan and shares were withheld to satisfy tax withholding on RSU vesting.

What was the acquisition price for the vested RSUs and the sale price?

The RSUs converted at a stated price of $0 (typical for vesting), and the reported sale price for 402 shares was $105.60 per share.

Who signed the Form 4 filing for Paul A. Stellato?

The Form 4 was signed by Matthew R. St. Louis, Attorney-in-Fact for Paul A. Stellato on 09/02/2025.